Mainz End Period Cash Flow vs Free Cash Flow Analysis

MYNZ Stock

USD 0.22 0.04 15.38%

Mainz Biomed financial indicator trend analysis is infinitely more than just investigating Mainz Biomed BV recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mainz Biomed BV is a good investment. Please check the relationship between Mainz Biomed End Period Cash Flow and its Free Cash Flow accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mainz Biomed BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

End Period Cash Flow vs Free Cash Flow

End Period Cash Flow vs Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mainz Biomed BV End Period Cash Flow account and Free Cash Flow. At this time, the significance of the direction appears to have pay attention.

The correlation between Mainz Biomed's End Period Cash Flow and Free Cash Flow is -0.72. Overlapping area represents the amount of variation of End Period Cash Flow that can explain the historical movement of Free Cash Flow in the same time period over historical financial statements of Mainz Biomed BV, assuming nothing else is changed. The correlation between historical values of Mainz Biomed's End Period Cash Flow and Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which End Period Cash Flow of Mainz Biomed BV are associated (or correlated) with its Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Free Cash Flow has no effect on the direction of End Period Cash Flow i.e., Mainz Biomed's End Period Cash Flow and Free Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.72

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

End Period Cash Flow

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Most indicators from Mainz Biomed's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mainz Biomed BV current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mainz Biomed BV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Issuance Of Capital Stock is likely to rise to about 9 M in 2024, whereas Selling General Administrative is likely to drop slightly above 8.9 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	339.2K	289.3K	809.6K	419.9K
Depreciation And Amortization	209.9K	459.4K	1.0M	1.1M

Interest Expense Depreciation And Amortization

Mainz Biomed fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Capital Lease Obligations	Other Current Assets	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital
Total Assets		0.65	0.94	0.76	0.94	0.77	0.93	-0.83	-0.85	0.83	0.96	0.65	0.72	0.96	0.8	0.4	0.2	0.89	0.94	0.79	0.99	0.77	0.63	0.98	0.87	0.73
Short Long Term Debt Total	0.65		0.79	0.85	0.36	0.84	0.5	-0.14	-0.85	0.83	0.43	0.86	0.39	0.43	0.82	0.51	0.75	0.86	0.69	0.98	0.57	0.84	0.86	0.48	0.93	0.0
Other Current Liab	0.94	0.79		0.82	0.8	0.85	0.78	-0.66	-0.89	0.84	0.85	0.74	0.51	0.85	0.88	0.48	0.37	0.98	0.83	0.89	0.91	0.85	0.72	0.87	0.9	0.54
Total Current Liabilities	0.76	0.85	0.82		0.56	0.99	0.6	-0.29	-0.99	0.99	0.61	0.99	0.5	0.61	0.98	0.48	0.63	0.85	0.75	0.88	0.7	1.0	0.98	0.65	0.9	0.14
Total Stockholder Equity	0.94	0.36	0.8	0.56		0.57	0.93	-0.96	-0.67	0.65	1.0	0.42	0.72	1.0	0.62	0.25	-0.07	0.71	0.86	0.54	0.97	0.58	0.4	0.99	0.65	0.9
Property Plant And Equipment Net	0.77	0.84	0.85	0.99	0.57		0.58	-0.32	-0.99	0.98	0.63	0.98	0.44	0.63	0.99	0.53	0.57	0.88	0.73	0.88	0.72	1.0	0.97	0.66	0.89	0.17
Current Deferred Revenue	0.93	0.5	0.78	0.6	0.93	0.58		-0.86	-0.7	0.71	0.94	0.49	0.9	0.94	0.6	0.15	0.15	0.69	0.97	0.64	0.94	0.6	0.47	0.95	0.76	0.81
Net Debt	-0.83	-0.14	-0.66	-0.29	-0.96	-0.32	-0.86		0.43	-0.41	-0.94	-0.15	-0.64	-0.94	-0.38	-0.13	0.29	-0.54	-0.73	-0.33	-0.88	-0.32	-0.12	-0.92	-0.45	-0.99
Retained Earnings	-0.85	-0.85	-0.89	-0.99	-0.67	-0.99	-0.7	0.43		-0.99	-0.72	-0.95	-0.57	-0.72	-0.98	-0.49	-0.56	-0.91	-0.83	-0.91	-0.8	-0.99	-0.94	-0.75	-0.94	-0.28
Accounts Payable	0.83	0.83	0.84	0.99	0.65	0.98	0.71	-0.41	-0.99		0.7	0.96	0.62	0.7	0.96	0.44	0.58	0.86	0.84	0.88	0.78	0.98	0.95	0.74	0.92	0.27
Cash	0.96	0.43	0.85	0.61	1.0	0.63	0.94	-0.94	-0.72	0.7		0.49	0.73	1.0	0.67	0.27	0.0	0.76	0.88	0.6	0.98	0.63	0.46	1.0	0.71	0.87
Non Current Assets Total	0.65	0.86	0.74	0.99	0.42	0.98	0.49	-0.15	-0.95	0.96	0.49		0.42	0.49	0.95	0.49	0.69	0.8	0.66	0.86	0.59	0.98	1.0	0.53	0.86	-0.01
Long Term Debt	0.72	0.39	0.51	0.5	0.72	0.44	0.9	-0.64	-0.57	0.62	0.73	0.42		0.73	0.41	-0.14	0.29	0.42	0.89	0.49	0.71	0.47	0.42	0.74	0.62	0.61
Cash And Short Term Investments	0.96	0.43	0.85	0.61	1.0	0.63	0.94	-0.94	-0.72	0.7	1.0	0.49	0.73		0.67	0.27	0.0	0.76	0.88	0.6	0.98	0.63	0.46	1.0	0.71	0.87
Net Receivables	0.8	0.82	0.88	0.98	0.62	0.99	0.6	-0.38	-0.98	0.96	0.67	0.95	0.41	0.67		0.56	0.5	0.91	0.72	0.87	0.76	0.99	0.94	0.7	0.88	0.23
Common Stock Shares Outstanding	0.4	0.51	0.48	0.48	0.25	0.53	0.15	-0.13	-0.49	0.44	0.27	0.49	-0.14	0.27	0.56		-0.07	0.62	0.25	0.54	0.38	0.51	0.47	0.29	0.51	0.02
Non Current Liabilities Total	0.2	0.75	0.37	0.63	-0.07	0.57	0.15	0.29	-0.56	0.58	0.0	0.69	0.29	0.0	0.5	-0.07		0.4	0.36	0.64	0.11	0.59	0.71	0.05	0.58	-0.38
Capital Lease Obligations	0.89	0.86	0.98	0.85	0.71	0.88	0.69	-0.54	-0.91	0.86	0.76	0.8	0.42	0.76	0.91	0.62	0.4		0.79	0.94	0.85	0.88	0.78	0.79	0.93	0.41
Other Current Assets	0.94	0.69	0.83	0.75	0.86	0.73	0.97	-0.73	-0.83	0.84	0.88	0.66	0.89	0.88	0.72	0.25	0.36	0.79		0.79	0.92	0.74	0.65	0.91	0.89	0.64
Total Liab	0.79	0.98	0.89	0.88	0.54	0.88	0.64	-0.33	-0.91	0.88	0.6	0.86	0.49	0.6	0.87	0.54	0.64	0.94	0.79		0.73	0.88	0.85	0.65	0.98	0.2
Net Invested Capital	0.99	0.57	0.91	0.7	0.97	0.72	0.94	-0.88	-0.8	0.78	0.98	0.59	0.71	0.98	0.76	0.38	0.11	0.85	0.92	0.73		0.72	0.56	0.99	0.81	0.79
Property Plant And Equipment Gross	0.77	0.84	0.85	1.0	0.58	1.0	0.6	-0.32	-0.99	0.98	0.63	0.98	0.47	0.63	0.99	0.51	0.59	0.88	0.74	0.88	0.72		0.97	0.67	0.9	0.17
Short Long Term Debt	0.63	0.86	0.72	0.98	0.4	0.97	0.47	-0.12	-0.94	0.95	0.46	1.0	0.42	0.46	0.94	0.47	0.71	0.78	0.65	0.85	0.56	0.97		0.5	0.85	-0.04
Total Current Assets	0.98	0.48	0.87	0.65	0.99	0.66	0.95	-0.92	-0.75	0.74	1.0	0.53	0.74	1.0	0.7	0.29	0.05	0.79	0.91	0.65	0.99	0.67	0.5		0.75	0.85
Capital Stock	0.87	0.93	0.9	0.9	0.65	0.89	0.76	-0.45	-0.94	0.92	0.71	0.86	0.62	0.71	0.88	0.51	0.58	0.93	0.89	0.98	0.81	0.9	0.85	0.75		0.32
Net Working Capital	0.73	0.0	0.54	0.14	0.9	0.17	0.81	-0.99	-0.28	0.27	0.87	-0.01	0.61	0.87	0.23	0.02	-0.38	0.41	0.64	0.2	0.79	0.17	-0.04	0.85	0.32

Click cells to compare fundamentals

Mainz Biomed Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mainz End Period Cash Flow vs Free Cash Flow Analysis

End Period Cash Flow vs Free Cash Flow

End Period Cash Flow vs Free Cash Flow Correlation Analysis

Correlation Coefficient

End Period Cash Flow

Free Cash Flow

Mainz Biomed fundamental ratios Correlations

Mainz Biomed Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

Additional Tools for Mainz Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Property Plant And Equipment Gross	+ 1.0	Total Current Liabilities
Cash	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Total Stockholder Equity
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash

Property Plant And Equipment Gross	- 0.99	Retained Earnings
Accounts Payable	- 0.99	Retained Earnings
Net Working Capital	- 0.99	Net Debt
Retained Earnings	- 0.99	Property Plant And Equipment Net
Retained Earnings	- 0.99	Total Current Liabilities
Net Receivables	- 0.98	Retained Earnings